Fingerprint
Dive into the research topics of 'Phase I-II trial of ONYX-015 in combination with MAP chemotherapy in patients with advanced sarcomas'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Phase I-II trial of ONYX-015 in combination with MAP chemotherapy in patients with advanced sarcomas
E. Galanis, S. H. Okuno, A. G. Nascimento, B. D. Lewis, R. A. Lee, A. M. Oliveira, J. A. Sloan, P. Atherton, J. H. Edmonson, C. Erlichman, B. Randlev, Q. Wang, S. Freeman, J. Rubin
Research output: Contribution to journal › Article › peer-review
128
Scopus
citations